Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study

被引：0
|
作者：
Otte, C. [1 ]
Hinkelmann, K. [1 ]
Moritz, S. [1 ]
Yassouridis, A. [2 ]
Jahn, H. [1 ]
Wiedemann, K. [1 ]
Kellner, M. [1 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat, Hamburg, Germany
[2] Max Planck Inst Psychiat, D-80804 Munich, Germany
来源：
PHARMACOPSYCHIATRY | 2009年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
A120
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [1] Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study
    Otte, Christian
    Hinkelmann, Kim
    Moritz, Steffen
    Yassouridis, Alexander
    Jahn, Holger
    Wiedemann, Klaus
    Kellner, Michael
    JOURNAL OF PSYCHIATRIC RESEARCH, 2010, 44 (06) : 339 - 346
  • [2] Dapiglutide for Obesity - A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study
    Nielsen, Casper Kjaesgaard
    Palsson, Thorir
    Jensen, Benjamin
    Johansen, Nicklas
    Pedersen, Miriam
    Forman, Julie
    Lund, Asger
    Knop, Filip Krag
    OBESITY, 2024, 32 : 182 - 182
  • [3] Dapiglutide for the treatment of obesity: a double-blind, placebo-controlled, proof-of-concept study
    Nielsen, C.
    Palsson, T.
    Jensen, B. A. H.
    Johansen, N. J.
    Pedersen, M. G.
    Forman, J. L.
    Lund, A. B.
    Knop, F. K.
    DIABETOLOGIA, 2024, 67 : S512 - S512
  • [4] A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
    Ricardo Alexandre Toniolo
    Michelle Silva
    Francy de Brito Ferreira Fernandes
    José Antonio de Mello Siqueira Amaral
    Rodrigo da Silva Dias
    Beny Lafer
    Journal of Neural Transmission, 2018, 125 : 247 - 257
  • [5] A randomized, double-blind, placebo-controlled, proof-of-concept trial of creatine monohydrate as adjunctive treatment for bipolar depression
    Toniolo, Ricardo Alexandre
    Silva, Michelle
    Ferreira Fernandes, Francy de Brito
    de Mello Siqueira Amaral, Jose Antonio
    Dias, Rodrigo da Silva
    Lafer, Beny
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (02) : 247 - 257
  • [6] Treatment of postpartum depression with psychotherapy and add-on sertraline: a double-blind, randomised, placebo-controlled study
    Bloch, M.
    Meiboom, H.
    Lorberblat, M.
    Aharonov, I.
    Bluvshtein, I.
    Ben-Itzhak, S.
    Schreiber, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S359 - S360
  • [7] Efficacy of ozone therapy as an add-on treatment in fibromyalgia: A randomized double-blind placebo-controlled study
    Sucuoglu, Hamza
    Soydas, Nalan
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2023, 36 (02) : 357 - 366
  • [8] Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study
    Bergman, Joseph
    Miodownik, Chanoch
    Bersudsky, Yuly
    Sokolik, Shmuel
    Lerner, Paul P.
    Kreinin, Anatoly
    Polakiewicz, Jacob
    Lerner, Vladimir
    CLINICAL NEUROPHARMACOLOGY, 2013, 36 (03) : 73 - 77
  • [9] Olanzapine as an add-on treatment in migraine status: A randomized double-blind, placebo-controlled, pilot study
    Mogollon, Johana
    Serrano, Ana
    de Freitez, Alix Padron
    Uzcategui, Euderruh
    Baptista, Trino
    EUROPEAN JOURNAL OF PSYCHIATRY, 2012, 26 (04): : 260 - 265
  • [10] The Effect of Sertraline Add-On to Brief Dynamic Psychotherapy for the Treatment of Postpartum Depression: A Randomized, Double-Blind, Placebo-Controlled Study
    Bloch, Miki
    Meiboom, Hadas
    Lorberblatt, Merona
    Bluvstein, Irit
    Aharonov, Inbar
    Schreiber, Shaul
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (02) : 235 - 241
12345